QuidelOrtho

04/23/2026

━━━━━━━━━━━━━━━━━━━━━━━━
Mission recording available – On demand
━━━━━━━━━━━━━━━━━━━━━━━━

Transmission decrypted:
Thank you to all who joined the Lab Week keynote with Daniel Kraft.

Missed the live event? The full session is now available on demand – discover how AI helps reduce workload and enhances the critical work powering patient care

https://gateway.on24.com/wcc/eh/3300431/category/147966/2026-lab-week?partnerref=social&utm_source=hootsuite&utm_medium=facebook&utm_term=quidelortho&utm_content=5e7c849f-eafc-4dd3-8160-e9476c7b96eb&utm_campaign=LabWeek%3AWebinarOndemand

04/23/2026

Congenital syphilis cases in the U.S. have increased more than tenfold since 2012, signaling a deepening public health crisis that demands immediate action across healthcare systems and communities.

Reversing this trend will require updated screening guidelines, advances in diagnostic technology and coordinated efforts to expand access and reduce stigma. In an interview with Contagion Live, QuidelOrtho's Dr. Lily Li breaks down the factors driving the resurgence and the strategies needed to address it.

Learn more: https://www.contagionlive.com/view/as-congenital-syphilis-continues-to-increase-diagnostics-and-education-play-key-roles-to-reduce-incidence-rates

Lily Li, MD, PhD, MBA, discusses factors for increasing incidence rates including low awareness, asymptomatic spread, and gaps in testing and care access, and strategies to increase early. She also provides a brief overview for some of the testing options for the infectious disease.

04/22/2026

Sustainability matters in healthcare. This , QuidelOrtho reaffirms our commitment to responsible manufacturing, reduced environmental impact and a healthier planet for all.

https://www.quidelortho.com/global/en/our-company/sustainability

04/22/2026

Congenital syphilis is entirely preventable, yet cases continue to increase nationwide.

This episode of QuidelOrtho Science Bytes explores how testing algorithms work, why single prenatal screening isn’t enough and how opt‑out screening in emergency departments can catch infections before harm occurs.

Listen now: https://ow.ly/HG3l50YK5lX

04/20/2026

━━━━━━━━━━━━━━━━━━━━━━━━
Final call – Webinar t minus 24 hours
━━━━━━━━━━━━━━━━━━━━━━━━

Mission Control alert:
Innovation is accelerating – and it’s here to support your mission, helping reduce workload, streamline processes and elevate patient care across the diagnostic journey.

Tomorrow, join Daniel Kraft for a Lab Week webinar on how AI can assist laboratorians without replacing the expertise that drives every result.

Happening tomorrow: Join Daniel Kraft for a Lab Week webinar on how AI can assist laboratorians without replacing the expertise that drives every result.
https://gateway.on24.com/wcc/eh/3300431/category/147966/2026-lab-week?partnerref=social&utm_source=hootsuite&utm_medium=facebook&utm_term=quidelortho&utm_content=ba9ecb07-f859-4c33-9751-f5ee122e019e&utm_campaign=LabWeek%3AWebinar

04/20/2026

We’ve completed the acquisition of LEX Diagnostics following U.S. Food and Drug Administration 510(k) clearance and CLIA waiver of the LEX VELO™ System. Read the full press release here: https://www.prnewswire.com/news-releases/quidelortho-corporation-completes-acquisition-of-lex-diagnostics-302746364.html?tc=eml_cleartime.

04/15/2026

Early-stage syphilis cases are declining, but congenital syphilis continues to rise. Why?

In the latest episode of QuidelOrtho Science Bytes, Andrea Ott‑Vasconi breaks down what the data shows, where infections are being missed. and how repeat screening – especially during pregnancy – can prevent severe outcomes.

Listen now: https://ow.ly/SjU850YK5g5

04/07/2026

At QuidelOrtho, we're committed to advancing diagnostic solutions that empower healthier communities around the world. This , we celebrate the future of global health and the partners who make progress possible.

https://www.quidelortho.com/global/en

04/06/2026

We are proud to announce the launch of the updated QOPlus Customer Portal — your one-stop shop for managing all your QuidelOrtho solutions and services. Login or register now at qoplus.quidelortho.com to see how it can make your operation smarter and easier to manage.

04/01/2026

Partnering for Impact: QuidelOrtho’s Rapid Response to the Dengue Outbreak in Timor-Leste

Timor-Leste is currently facing a significant dengue outbreak, placing immense pressure on the nation's healthcare system.

In a collaborative humanitarian effort with Stamford Medical and the Australian Embassy in Timor-Leste, our team facilitated the urgent delivery of QuidelOrtho reagents. This donation includes a total of 86,990 dry slides (from Australia embassy Timor Leste to Nacional Hospital). These critical supplies enable the hospital to perform life-saving laboratory tests – including liver, kidney, general chemistry and electrolyte monitoring on VITROS™ 4600 and VITROS™ 350 Chemistry Systems.

This initiative reflects our core mission: Advancing the Power of Diagnostics for a Healthier Future for All. By prioritizing rapid access to reliable diagnostic tools during public health crises, we aim to provide the critical support clinicians need to save lives and protect the wellbeing of the community.

We are honored to stand alongside our partners and the people of Timor-Leste during this challenging time.

03/25/2026

Don't miss QuidelOrtho Science Bytes - Episode 44

"Take heart: How point-of-care cardiac diagnostics save time and lives"
– More than 30 minutes reduced wait times
– Improved patient flow
– Enhanced departmental efficiency

Drs. Than and Collinson share insights on point-of-care testing in the emergency department.

Listen now: https://www.quidelortho.com/content/quidelortho/fda/us/en/resources/podcasts/Take-heart--How-Point-of-Care-Cardiac-Diagnostics-Save-Time-and-Lives.html

03/24/2026

Pleased to welcome Nathaniel “Nate” Sisitsky has joined QuidelOrtho as Chief Legal Officer, bringing 25+ years of legal and governance expertise in life sciences and tech.

Welcome to the team, Nate!

/PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, is pleased to announce the...